Cargando…

Pharmacogenetics of Praziquantel Metabolism: Evaluating the Cytochrome P450 Genes of Zimbabwean Patients During a Schistosomiasis Treatment

Schistosomiasis is a parasitic disease infecting over 236 million people annually, with the majority affected residing on the African continent. Control of this disease is reliant on the drug praziquantel (PZQ), with treatment success dependent on an individual reaching PZQ concentrations lethal to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zdesenko, Grace, Mduluza, Takafira, Mutapi, Francisca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213834/ https://www.ncbi.nlm.nih.gov/pubmed/35754834 http://dx.doi.org/10.3389/fgene.2022.914372

Ejemplares similares

Drug metabolism and pharmacokinetics of praziquantel: A review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models
por: Zdesenko, Grace, et al.
Publicado: (2020)

Frequency distribution of cytokine and associated transcription factor single nucleotide polymorphisms in Zimbabweans: Impact on schistosome infection and cytokine levels
por: Hanton, Andrew John, et al.
Publicado: (2022)

Putting the treatment of paediatric schistosomiasis into context
por: Mduluza, Takafira, et al.
Publicado: (2017)

Seroepidemiology of Plasmodium species infections in Zimbabwean population
por: Amanfo, Seth A., et al.
Publicado: (2016)

Comparative Assessment of Health Benefits of Praziquantel Treatment of Urogenital Schistosomiasis in Preschool and Primary School-Aged Children
por: Wami, Welcome M., et al.
Publicado: (2016)

Association between Micronutrients (Vitamin A, D, Iron) and Schistosome-Specific Cytokine Responses in Zimbabweans Exposed to Schistosoma haematobium
por: Reilly, Liam, et al.
Publicado: (2012)

Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis
por: Pearson, Mark S., et al.
Publicado: (2021)

Fungal allergic sensitisation in young rural Zimbabwean children: Gut mycobiome and seroreactivity characteristics
por: Pfavayi, Lorraine Tsitsi, et al.
Publicado: (2021)

The Identification and Characterization of Immunoreactive Fungal Proteins Recognized by Sera from Zimbabweans Sensitized to Fungi
por: Pfavayi, Lorraine Tsitsi, et al.
Publicado: (2022)

Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-γ, IL-4, IL-5 and IL-10 with age
por: Mutapi, Francisca, et al.
Publicado: (2007)

Association of schistosomiasis and risk of prostate cancer development in residents of Murehwa rural community, Zimbabwe
por: Choto, Emilia T., et al.
Publicado: (2020)

Atopy Is Inversely Related to Schistosome Infection Intensity: A Comparative Study in Zimbabwean Villages with Distinct Levels of Schistosoma haematobium Infection
por: Rujeni, Nadine, et al.
Publicado: (2012)

Identifying and Evaluating Field Indicators of Urogenital Schistosomiasis-Related Morbidity in Preschool-Aged Children
por: Wami, Welcome M., et al.
Publicado: (2015)

Interleukin-10 and tumour necrosis factor alpha promoter region polymorphisms and susceptibility to urogenital schistosomiasis in young Zimbabwean children living in Schistosoma haematobium endemic regions
por: Marume, Amos, et al.
Publicado: (2020)

Assessing early child development and its association with stunting and schistosome infections in rural Zimbabwean children using the Griffiths Scales of Child Development
por: Mutapi, Francisca, et al.
Publicado: (2021)

Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel
por: Mutapi, Francisca, et al.
Publicado: (2011)

Cytokine Responses to the Anti-schistosome Vaccine Candidate Antigen Glutathione-S-transferase Vary with Host Age and Are Boosted by Praziquantel Treatment
por: Bourke, Claire D., et al.
Publicado: (2014)

Decrease in Seminal HIV-1 RNA Load After Praziquantel Treatment of Urogenital Schistosomiasis Coinfection in HIV-Positive Men—An Observational Study
por: Midzi, Nicholas, et al.
Publicado: (2017)

Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity
por: Chisango, Tawanda J., et al.
Publicado: (2019)

Clinical Pharmacogenetics of Cytochrome P450-Associated Drugs in Children
por: Aka, Ida, et al.
Publicado: (2017)

The role of pharmacogenetics of cytochrome P450s in phenytoin-induced DRESS syndrome
por: Yaşar, Ümit
Publicado: (2018)

Elevation of C-reactive protein, P-selectin and Resistin as potential inflammatory biomarkers of urogenital Schistosomiasis exposure in preschool children
por: Chimponda, Theresa N., et al.
Publicado: (2019)

Six rounds of annual praziquantel treatment during a national helminth control program significantly reduced schistosome infection and morbidity levels in a cohort of schoolchildren in Zimbabwe
por: Mduluza, Takafira, et al.
Publicado: (2020)

Polymorphism in Cytochrome P450 3A4 Is Ethnicity Related
por: Guttman, Yelena, et al.
Publicado: (2019)

Integrated Analysis of Innate, Th1, Th2, Th17, and Regulatory Cytokines Identifies Changes in Immune Polarisation Following Treatment of Human Schistosomiasis
por: Bourke, Claire D., et al.
Publicado: (2013)

Phylogenetic analysis of the cytochrome P450 (CYP450) nucleotide sequences of the horse and predicted CYP450s of the white rhinoceros (Ceratotherium simum) and other mammalian species
por: Leiberich, Marion, et al.
Publicado: (2018)

Clinical Implications of Combinatorial Pharmacogenomic Tests Based on Cytochrome P450 Variant Selection
por: Sayer, Michael, et al.
Publicado: (2021)

Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria
por: IMAI, NATSUKO, et al.
Publicado: (2011)

Pharmacogenetic Testing of Cytochrome P450 Drug Metabolizing Enzymes in a Case Series of Patients with Prader-Willi Syndrome
por: Forster, Janice, et al.
Publicado: (2021)

The gut microbiome but not the resistome is associated with urogenital schistosomiasis in preschool-aged children
por: Osakunor, Derick N. M., et al.
Publicado: (2020)

Effect of Pharmacogenetics Variations on Praziquantel Plasma Concentrations and Schistosomiasis Treatment Outcomes Among Infected School-Aged Children in Tanzania
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2021)

Regulatory and Activated T Cells in Human Schistosoma haematobium Infections
por: Nausch, Norman, et al.
Publicado: (2011)

Systemic Sclerosis in Zimbabwe: Autoantibody Biomarkers, Clinical, and Laboratory Correlates
por: Sibanda, Elopy N., et al.
Publicado: (2021)

Field evaluation of a new antibody-based diagnostic for Schistosoma haematobium and S. mansoni at the point-of-care in northeast Zimbabwe
por: Nausch, Norman, et al.
Publicado: (2014)

Pharmacogenomics of Cytochrome P450 3A4: Recent Progress Toward the “Missing Heritability” Problem
por: Klein, Kathrin, et al.
Publicado: (2013)

Schistosoma haematobium infection levels determine the effect of praziquantel treatment on anti-schistosome and anti-mite antibodies
por: RUJENI, N, et al.
Publicado: (2012)

Positive impact of preventative chemotherapy during a national helminth control program: Perception and KAP
por: Mutapi, Francisca, et al.
Publicado: (2020)

Evaluation of Artesunate and Praziquantel Combination Therapy in Murine Schistosomiasis mansoni
por: HEGAZY, Laila Abdel Moniem, et al.
Publicado: (2018)

Schistosoma haematobium infection is associated with alterations in energy and purine-related metabolism in preschool-aged children
por: Osakunor, Derick N. M., et al.
Publicado: (2020)

Praziquantel for the treatment of schistosomiasis during human pregnancy
por: Friedman, Jennifer F, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_krb5qcm4ji1cae36v2gnno4ocu